News about Global Pharma

Leanbio Invests Additional Euro 20M in Barcelona GMP Biologics Plant

Spanning over 3500m2, the facility will house three production lines capable of manufacturing recombinant proteins and antibodies in different expression systems, as well as plasmid DNA and messenger RNA for advanced thera

Global Pharma | 19/12/2023 | By Manvi |  791

Sun Pharma to Acquire 16.7% in Lyndra Therapeutics for USD 30 Million

Sun Pharma stated that the strategic investment is to support development of innovative pharmaceutical delivery technologies and get access to the technology for certain molecules and territories.

Global Pharma | 19/12/2023 | By Manvi |  374

Global CDMO Agno Pharma Completes Acquisition of Particle Sciences

The acquisition includes the drug product formulation technology behind the Particle Sciences Inc. business as well as the Bethlehem, PA, development and manufacturing site with approximately 65 employees.

Global Pharma | 19/12/2023 | By Manvi |  858

Sun Pharma, Lupin Recall Drugs in US Market: USFDA

Sun Pharmaceutical Industries is recalling 96,192 bottles of Liothyronine Sodium Tablets in the US that are used to treat an underactive thyroid. The company is recalling the lot due to "failed impurities/degradation specifications", the USFDA stated.

Global Pharma | 19/12/2023 | By Manvi |  647

ACG Joins Coveted List of WEF's Global Lighthouse Network

ACG celebrated the inclusion of its capsule manufacturing facility in Pithampur, India, into the esteemed Global Lighthouse Network (GLN) by the World Economic Forum.

Global Pharma | 19/12/2023 | By Manvi |  267

Pfizer Completes USD 43 Billion Acquisition of Seagen

Pfizer have announced the successful completion of its acquisition of Seagen Inc, a global biotechnology company that discovers, develops and commercialises transformative cancer medicines.

Global Pharma | 18/12/2023 | By Manvi |  1162

Lupin Receives Approval from US FDA for Allopurinol Tablets

The product will be manufactured at Lupin's Pithampur facility in India.

Global Pharma | 18/12/2023 | By Manvi |  167

Zydus Gets Final Approval from USFDA for Darunavir Tablets 600 mg and 800 mg and Tentative Approval for 75 mg and 150 mg Tablets

Zydus Lifesciences Limited (including its subsidiaries/affiliates hereafter referred to as "Zydus") has received final approval from the United States Food and Drug Administration (USFDA) for Darunavir Tablets 600 mg and 800 mg, and tentative approval for 75 mg and 150 mg tablets (USRLD: Prezista® Tablets, 75 mg, 150 mg, 600 mg, and 800 mg).

Global Pharma | 18/12/2023 | By Manvi |  823

Cipla Limited Invests INR 42 Crore in GoApptiv Private Limited

In line with Cipla’s ambition to strengthen investments in channels of the future, this development will further expand Cipla’s presence across the healthcare continuum, especially to the underserved population by enabling greater access to lifesaving treatments.

Global Pharma | 18/12/2023 | By Manvi |  335

Aptar Pharma Unveils the Grand Opening of its New Mumbai Facility

Aptar Pharma Inaugurates its New Aptar Mumbai Site to Increase Manufacturing Capabilities in South East Asia

Global Pharma | 18/12/2023 | By Manvi |  658